Shilpa Pharma proudly delivers world-class CDMO services to France, supporting pharmaceutical and biotech innovators with high-quality, compliant, and scalable manufacturing solutions. As a globally trusted contract development and manufacturing organization, we combine European-quality standards, cutting-edge technology, and deep scientific expertise to help French companies accelerate their pipeline from development to commercial success.
With global regulatory approvals including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA, Shilpa Pharma is recognized for its strong quality systems, unmatched technical capabilities, and proven track record in regulated markets. Our advanced facilities specialize in oncology, high-potency APIs, complex generics, specialty therapeutics, biologics, and end-to-end formulation development—all backed by strict confidentiality and reliable supply performance.
Whether you are seeking cost-effective large-scale manufacturing, high-potency handling expertise, or a trusted CDMO partner for advanced formulations, Shilpa Pharma delivers solutions engineered for the French pharmaceutical market. We focus on precision, compliance, innovation, and on-time delivery, making us the preferred choice for companies looking for dependable CDMO services in France.
Partner with Shilpa Pharma—where world-class science meets world-class manufacturing to support France’s growing pharmaceutical and biotech landscape.



Leading the Way in Pharma Innovation

Established

R&D workforce

Team size

Manufacturing site

Audits

Customers

Projects
Shilpa Pharma is consistently chosen by leading pharmaceutical companies worldwide for our precision, reliability, and unmatched technical expertise. With strong capabilities in CDMO service in France, we support partners who demand world-class quality and flawless regulatory compliance.
What sets us apart is our ability to manufacture complex, rare, and high-value chemicals that very few companies in the world can produce. From advanced oncology molecules to specialty intermediates, our teams follow strict global guidelines at every step — ensuring purity, safety, and consistency.
Companies across Europe and beyond rely on our transparent processes, strong documentation practices, and proven track record of delivering on time, every time. When global brands need a manufacturing partner they can trust, they choose Shilpa Pharma — because excellence here is not an option, it’s a standard.
Shilpa Pharma is a globally trusted partner for CDMO API manufacturing and supply in France, delivering high-quality Active Pharmaceutical Ingredients that meet the strictest international regulatory standards. With decades of expertise in complex chemistry, oncology APIs, HPAPIs, peptides, and rare specialty compounds, we support French pharmaceutical and biotech companies with reliable, scalable, and compliant API solutions.
Our world-class manufacturing facilities in India operate under rigorous certifications, including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA, ensuring every API manufactured aligns with global quality, safety, and documentation expectations. From early-stage development to commercial-scale production, our teams bring deep scientific knowledge, robust process optimization, and advanced containment capabilities.
We specialize in:
With strong infrastructure, automated systems, and strict impurity profiling, Shilpa Pharma ensures consistency, purity, and timely supply to the French market. Our CDMO approach is built on transparency, regulatory excellence, and long-term partnership — helping companies de-risk manufacturing, accelerate launches, and achieve commercial success.
Whether you need a dependable supplier, a development partner, or full CDMO support, Shilpa Pharma offers end-to-end API solutions from India to France, backed by trusted quality and scientific strength.
Get our capability overview via email